10-Q
Quarterly Report
Autonomix Medical, Inc.
AMIX
NASDAQ
CIK: 1617867
File #: 001-41940
Balance Sheet
24 line items · 2 periods
XBRL
| Item | Sep 30, 2025 | Mar 31, 2025 |
|---|---|---|
Current assets: | ||
Cash and cash equivalents | 7,477,000 | 9,136,000 |
Other current assets | 416,000 | 473,000 |
Total current assets | 7,893,000 | 9,609,000 |
Long term assets: | ||
Fixed assets, net | 16,000 | 21,000 |
Deferred offering costs | 23,000 | 176,000 |
Total long term assets | 39,000 | 197,000 |
Total Assets | 7,932,000 | 9,806,000 |
Current liabilities: | ||
Accounts payable | 842,000 | 676,000 |
Accrued expenses | 645,000 | 1,031,000 |
Total current liabilities | 1,487,000 | 1,707,000 |
Total Liabilities | 1,487,000 | 1,707,000 |
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2025 and March 31, 2025, respectively | 0 | 0 |
Common stock, $0.001 par value, 500,000,000 shares authorized, 6,194,147 and 2,497,033 shares issued and outstanding as of September 30, 2025 and March 31, 2025, respectively | 6,000 | 2,000 |
Additional paid-in capital | 67,606,000 | 58,476,000 |
Accumulated deficit | (61,167,000) | (50,379,000) |
Total Stockholders' Equity | 6,445,000 | 8,099,000 |
Common Stock | 6,000 | 2,000 |
Additional Paid-in Capital | 67,606,000 | 58,476,000 |
Retained Earnings | (61,167,000) | (50,379,000) |
Total Liabilities and Stockholders' Equity | 7,932,000 | 9,806,000 |